Pediatricians and primary care providers (PCPs) are the first-line clinicians for children, adolescents, and young adults. The prevalence of psychiatric disorders within this population is high, with depression, anxiety and ADHD being most common. The morbidity and mortality of these disorders is significant; however, they remain under-treated. Given the limitations of referral to specialty care, PCPs are tasked with managing these illnesses. Both in our experience working in a consultation center and based on the literature, PCPs face many barriers to doing so, including limitations in knowledge about and comfort in prescribing psychiatric medications.

By 8th grade, 20% of US high school students in a large national study report having used any illicit drug (including marijuana) and 10% of those same 8th graders report having had alcohol in the month prior to the survey. By the time of graduation, nearly half of high schoolers have used illicit drugs and more than one third had drunk alcohol in the previous month. Adolescent and young adult substance abuse have significant impacts on current functioning and long-term outcomes. Pediatricians and primary care providers are first line in identifying and responding to these concerns. This session will focus on reviewing the risk factors for substance use disorders, validated screening tools, treatment and referral in the primary care setting.

To Register

Click on the link to register https://forms.office.com/pages/responsepage.aspx?id=U7o9qE0SMk2I8LcoianpJu5p9-ldiXNMpSRhrPwpV3pUOVJGQUVFRVNaVTM5WFZCWkE5MUQ5NUpJNS4u


At the conclusion of this activity, the participants should be able to:

  • Identify obsessive-compulsive disorder in children and adolescents using the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria.
  • Describe evidence-based treatment for OCD including pharmacotherapy (SSRIs) and psychotherapeutic interventions (ERP, Family CBT).
  • Utilize SSRIs to implement evidence-based pharmacologic treatments for OCD.
  • Discuss how to appropriately manage related side effects of SSRIs.
Session date: 
01/23/2023 - 12:00pm to 1:00pm CST
Houston, TX
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.